BACKGROUND AND PURPOSE: The aim of this study was to determine the impact of functional single nucleotide polymorphism (SNP) pathways involved in the ROS pathway, DNA repair, or TGFB1 signaling on acute or late normal toxicity as well as individual radiosensitivity. MATERIALS AND METHODS: Patients receiving breast-conserving surgery and radiotherapy were examined either for erythema (n = 83), fibrosis (n = 123), or individual radiosensitivity (n = 123). The 17 SNPs analyzed are involved in the ROS pathway (GSTP1, SOD2, NQO1, NOS3, XDH), DNA repair (XRCC1, XRCC3, XRCC6, ERCC2, LIG4, ATM) or TGFB signaling (SKIL, EP300, APC, AXIN1, TGFB1). Associations with biological and clinical endpoints were studied for single SNPs but especially for combinations of SNPs assuming that a SNP is either beneficial or deleterious and needs to be weighted. RESULTS: With one exception, no significant association was seen between a single SNP and the three endpoints studied. No significant associations were also observed when applying a multi-SNP model assuming that each SNP was deleterious. In contrast, significant associations were obtained when SNPs were suggested to be either beneficial or deleterious. These associations increased, when each SNP was weighted individually. Detailed analysis revealed that both erythema and individual radiosensitivity especially depend on SNPs affecting DNA repair and TGFB1 signaling, while SNPs in ROS pathway were of minor importance. CONCLUSION: Functional pathways of SNPs may be used to form a risk score allowing to predict acute and late radiation-induced toxicity but also to unravel the underlying biological mechanisms.
BACKGROUND AND PURPOSE: The aim of this study was to determine the impact of functional single nucleotide polymorphism (SNP) pathways involved in the ROS pathway, DNA repair, or TGFB1 signaling on acute or late normal toxicity as well as individual radiosensitivity. MATERIALS AND METHODS:Patients receiving breast-conserving surgery and radiotherapy were examined either for erythema (n = 83), fibrosis (n = 123), or individual radiosensitivity (n = 123). The 17 SNPs analyzed are involved in the ROS pathway (GSTP1, SOD2, NQO1, NOS3, XDH), DNA repair (XRCC1, XRCC3, XRCC6, ERCC2, LIG4, ATM) or TGFB signaling (SKIL, EP300, APC, AXIN1, TGFB1). Associations with biological and clinical endpoints were studied for single SNPs but especially for combinations of SNPs assuming that a SNP is either beneficial or deleterious and needs to be weighted. RESULTS: With one exception, no significant association was seen between a single SNP and the three endpoints studied. No significant associations were also observed when applying a multi-SNP model assuming that each SNP was deleterious. In contrast, significant associations were obtained when SNPs were suggested to be either beneficial or deleterious. These associations increased, when each SNP was weighted individually. Detailed analysis revealed that both erythema and individual radiosensitivity especially depend on SNPs affecting DNA repair and TGFB1 signaling, while SNPs in ROS pathway were of minor importance. CONCLUSION: Functional pathways of SNPs may be used to form a risk score allowing to predict acute and late radiation-induced toxicity but also to unravel the underlying biological mechanisms.
Authors: Catharine West; Barry S Rosenstein; Jan Alsner; David Azria; Gillian Barnett; Adrian Begg; Søren Bentzen; Neil Burnet; Jenny Chang-Claude; Eric Chuang; Charlotte Coles; Kim De Ruyck; Dirk De Ruysscher; Alison Dunning; Rebecca Elliott; Laura Fachal; Janet Hall; Karin Haustermans; Carsten Herskind; Tobias Hoelscher; Takashi Imai; Mayumi Iwakawa; Don Jones; Cecilia Kulich; Jan-Hans Langendijk; Peter O'Neils; Mahmut Ozsahin; Matthew Parliament; Andrzej Polanski; Barry Rosenstein; Daniela Seminara; Paul Symonds; Chris Talbot; Hubert Thierens; Ana Vega; Catherine West; John Yarnold Journal: Int J Radiat Oncol Biol Phys Date: 2010-04 Impact factor: 7.038
Authors: Jenny Chang-Claude; Odilia Popanda; Xiang-Lin Tan; Silke Kropp; Irmgard Helmbold; Dietrich von Fournier; Wulf Haase; Marie Luise Sautter-Bihl; Frederik Wenz; Peter Schmezer; Christine B Ambrosone Journal: Clin Cancer Res Date: 2005-07-01 Impact factor: 12.531
Authors: Qunyuan Zhang; Marguerite R Irvin; Donna K Arnett; Michael A Province; Ingrid Borecki Journal: Genet Epidemiol Date: 2011-08-04 Impact factor: 2.135
Authors: David Azria; Mahmut Ozsahin; Andrew Kramar; Sheila Peters; David P Atencio; Nigel E A Crompton; Françoise Mornex; André Pèlegrin; Jean-Bernard Dubois; René-Olivier Mirimanoff; Barry S Rosenstein Journal: Clin Cancer Res Date: 2008-10-01 Impact factor: 12.531
Authors: E-M Thurner; S Krenn-Pilko; U Langsenlehner; W Renner; A Gerger; K S Kapp; T Langsenlehner Journal: Strahlenther Onkol Date: 2014-01-16 Impact factor: 3.621
Authors: Nataliya Kuptsova; Jenny Chang-Claude; Silke Kropp; Irmgard Helmbold; Peter Schmezer; Dietrich von Fournier; Wulf Haase; Marie Luise Sautter-Bihl; Frederik Wenz; Kenan Onel; Christine B Ambrosone Journal: Int J Cancer Date: 2008-03-15 Impact factor: 7.396